Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -433,680 | -276,336 | -143,805 | -68,554 | -43,957 |
| Depreciation Amortization | -36,265 | -3,895 | 1,569 | 787 | 179 |
| Accounts receivable | 57 | 1,693 | -1,750 | N/A | N/A |
| Accounts payable and accrued liabilities | 4,347 | 243 | 1,071 | 318 | 278 |
| Other Working Capital | 11,931 | 5,757 | 10,584 | -15,389 | 599 |
| Other Operating Activity | 67,791 | 44,532 | 31,453 | 12,982 | 11,978 |
| Operating Cash Flow | $-385,819 | $-228,006 | $-100,878 | $-69,856 | $-30,923 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -157,404 | -585,480 | -19,616 | -89,231 | -174,220 |
| PPE Investments | -2,917 | -915 | -3,072 | -419 | -115 |
| Investing Cash Flow | $-160,321 | $-586,395 | $-22,688 | $-89,650 | $-174,335 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 98,581 |
| Common Stock Issued | 488,101 | 856,218 | 277,858 | 4,098 | 234,686 |
| Other Financing Activity | -4,728 | -441 | -283 | -439 | 72,016 |
| Financing Cash Flow | $483,373 | $855,777 | $277,575 | $3,659 | $405,283 |
| Beginning Cash Position | 248,590 | 207,214 | 53,205 | 209,052 | 9,027 |
| End Cash Position | 185,823 | 248,590 | 207,214 | 53,205 | 209,052 |
| Net Cash Flow | $-62,767 | $41,376 | $154,009 | $-155,847 | $200,025 |
| Free Cash Flow | |||||
| Operating Cash Flow | -385,819 | -228,006 | -100,878 | -69,856 | -30,923 |
| Capital Expenditure | -2,917 | -915 | -3,072 | -419 | -115 |
| Free Cash Flow | -388,736 | -228,921 | -103,950 | -70,275 | -31,038 |